In a study by de Bazelaire et al. [19], dynamic contrast MR imaging did not prove to be really discriminatory either, as intense early enhancement (>100 % before 90 s) was found in the majority of cases of inflammatory breast carcinoma and almost half of the patients with mastitis, the enhancement kinetics of both conditions being analogous produced by vascular endothelial growth factor (VEGF). This evidence concerns the gene VEGFA and inflammatory breast carcinoma.